108 CHAPTER 4 31 Labots, M. et al. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics 162, 99-107, doi:10.1016/j. jprot.2017.04.014 (2017). 32 van der Mijn, J. C. et al. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics. Journal of Proteomics 127, 259-263, doi:10.1016/j.jprot.2015.04.006 (2015). 33 Piersma, S. R. et al. Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines. J Proteomics 127, 247-258, doi:10.1016/j.jprot.2015.03.019 (2015). 34 Rush, J. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94-101, doi:10.1038/nbt1046 (2005). 35 Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.- range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26, 1367-1372, doi:10.1038/nbt.1511 (2008). 36 Marx, H. et al. A large synthetic peptide and phosphopeptide reference library for mass spectrometry-based proteomics. Nat Biotechnol 31, 557-+, doi:10.1038/nbt.2585 (2013). 37 Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust Hyperparameter Estimation Protects against Hypervariable Genes and Improves Power to Detect Differential Expression. Ann Appl Stat 10, 946-963, doi:10.1214/16-Aoas920 (2016). 38 Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, doi:ARTN e47 10.1093/nar/gkv007 (2015). 39 Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847-2849, doi:10.1093/bioinformatics/btw313 (2016). 40 Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504, doi:10.1101/gr.1239303 (2003). 41 Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449, doi:10.1093/bioinformatics/bti551 (2005). 42 Krug, K. et al. A Curated Resource for Phosphosite-specific Signature Analysis. Mol Cell Proteomics 18, 576-593, doi:10.1074/mcp.TIR118.000943 (2019). 43 Reich, M. et al. GenePattern 2.0. Nat Genet 38, 500-501, doi:DOI 10.1038/ng0506-500 (2006). 44 Beuselinck, B. et al. Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting. Clinical Cancer Research 21, 1329-1339, doi:10.1158/10780432.Ccr-14-1128 (2015). 45 Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47, D442-D450, doi:10.1093/nar/gky1106 (2019). 46 Cucchi, D. G. J. et al. Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors. Hemasphere 5, doi:ARTN e606 10.1097/HS9.0000000000000606 (2021).
RkJQdWJsaXNoZXIy MTk4NDMw